MAP Kinase Signaling in Lymphoma: A Novel Therapeutic Paradigm

Project: Research project

Project Details


The Gordon Lab will be looking at pre-clinical experiments with MEK inhibitors in cell lines and patient samples with apoptosis by Annexin V or the biologic end point. These experiments will be conducted by Sheila Prachand, Research Lab Manager.
Effective start/end date8/1/138/31/15


  • Tufts Medical Center, Inc. (5010960-SERV // R01CA164311)
  • National Cancer Institute (5010960-SERV // R01CA164311)


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.